Cover Image

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro

In the present study we tested, using the microscale thermophoresis technique, a small library of thionocarbamates, thiolocarbamates, sulfide and disulfide as potential lead compounds for SARS-CoV-2 Mpro drug design. The successfully identified binder is a representative of the thionocarbamates grou...

Full description

Saved in:

Bibliographic Details
Main Authors:	Katarzyna Papaj (Author), Patrycja Spychalska (Author), Katarzyna Hopko (Author), Patryk Kapica (Author), Andre Fisher (Author), Markus A. Lill (Author), Weronika Bagrowska (Author), Jakub Nowak (Author), Katarzyna Szleper (Author), Martin Smieško (Author), Anna Kasprzycka (Author), Artur Góra (Author)
Format:	Book
Published:	MDPI AG, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Selected Silyl Groups on the Anticancer Activity of 3,4-Dibromo-5-Hydroxy-Furan-2(5<i>H</i>)-One Derivatives
by: Radoslaw Kitel, et al.
Published: (2021)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020)

Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors
by: Justin Airas, et al.
Published: (2022)

Mono- and di-thiocarbamate inhibition studies of the δ-carbonic anhydrase TweCAδ from the marine diatom Thalassiosira weissflogii
by: Silvia Bua, et al.
Published: (2018)

<i>Reynoutria</i> Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study
by: Izabela Nawrot-Hadzik, et al.
Published: (2021)

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
by: Ting Xiao, et al.
Published: (2021)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022)

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
by: Letian Song, et al.
Published: (2024)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023)

Uji Aktivitas Senyawa Bahan Alam terhadap Enzim Mpro pada SARS-CoV-2 Secara In Silico
by: Syahrul Hidayat, et al.
Published: (2021)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020)

In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024)

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
by: Renhui Dai, et al.
Published: (2023)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
by: Min Zhang, et al.
Published: (2023)

Renal Function Predicts Outcomes in Patients with Ischaemic Stroke and Haemorrhagic Stroke
by: Katarzyna Snarska, et al.
Published: (2016)

Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro
by: Santiago M. Ruatta, et al.
Published: (2023)

Entamoeba histolytica - Pathogenic Protozoan of the Large Intestine in Humans
by: Piotr Nowak, et al.
Published: (2015)

Vitamin D in SARS-CoV-2 infection
by: Agnieszka Decyk, et al.
Published: (2022)

Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection
by: Zhen Xu, et al.
Published: (2022)

Professional stress and job satisfaction of nurses working in infectious diseases wards during the SARS-CoV-2 pandemic
by: Katarzyna Tomaszewska, et al.
Published: (2022)

Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study
by: Sarfraz Ahmad, et al.
Published: (2023)

The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023)

Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses
by: Chiranjib Chakraborty, et al.
Published: (2023)

Spiritual care for people suffering from dementia disorders - selected issues
by: Patrycja Zurzycka, et al.
Published: (2021)

Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals
by: Francisco Castillo, et al.
Published: (2024)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components
by: Devvret Verma, et al.
Published: (2021)

First reports of the psychological consequences of the SARS-CoV-2 pandemic. What appeared in the scientific literature between January and June 2020?
by: Marta Makara-Studzińska, et al.
Published: (2021)

In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
by: Anirudh Pratap Singh Raman, et al.
Published: (2022)

Autoimmune pancreatitis - role of intestinal microbiota in pathogenesis. Review of the literature
by: Katarzyna Wiejak, et al.
Published: (2024)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022)

Health locus of control among patients with type 2 diabetes - preliminary test results
by: Katarzyna Czyżowicz, et al.
Published: (2020)

Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
by: Sukanya Panikar, et al.
Published: (2021)

Selected aspects of narration in the integrated care of patients diagnosed with schizophrenia
by: Patrycja Zurzycka, et al.
Published: (2023)

Narration in medical care. Selected aspects of narrative medicine in psychiatry
by: Patrycja Zurzycka, et al.
Published: (2021)

Analysis of health behaviours of pregnant women in the perinatal period during the SARS-CoV-2 virus pandemic based on the Health Behaviour Inventory
by: Katarzyna Filipiak, et al.
Published: (2023)

Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75
by: Shengnan Yin, et al.
Published: (2022)

The influence of physical activity, specialized exercises and diet on pregnancy and delivery according to pregnant women attending a childbirth school
by: Julita Spychalska
Published: (2021)

Working conditions of medical staff and psychosocial burden during the SARS-CoV-2 pandemic on the example of a selected hospital
by: Katarzyna Tomaszewska, et al.
Published: (2023)

Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice
by: Patrycja Pańczyszyn-Trzewik, et al.
Published: (2024)